Skip Navigation

Rheumatology 2009 48(Supplement 3):iii8-iii13; doi:10.1093/rheumatology/ken482
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Matucci-Cerinic, M.
Right arrow Articles by Hachulla, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matucci-Cerinic, M.
Right arrow Articles by Hachulla, E.
Related Collections
Right arrow Systemic Sclerosis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

This article appears in the following Rheumatology issue: Ten years of partnership: translating ideas into progress in systemic sclerosis [View the issue table of contents]

Reviews

The complexity of managing systemic sclerosis: screening and diagnosis

M. Matucci-Cerinic1, V. Steen2, P. Nash3 and E. Hachulla4

1Department of Biomedicine, Centre DenoThe, Division of Rheumatology, AOUC University of Florence, Florence, Italy, 2Department of Medicine, Georgetown University, Washington DC, USA, 3Rheumatology Research Unit, Sunshine Coast Queensland Department of Medicine, University of Queensland, Queensland, Australia and 4Hôpital Claude-Huriez, University of Lille, Lille, France.

Correspondence to: M. Matucci-Cerinic, Department of Biomedicine, Centre DenoThe, Division of Rheumatology, AOUC University of Florence, Florence 50139, Italy. E-mail: cerinic{at}unifi.it


   Abstract

The difficulties inherent in diagnosing, screening and treating SSc are reflected by the complex pathology of the disease, which involves the development of severe organ-based complications that reduce both quality of life and overall survival. Early detection and prompt treatment of such complications depend upon a successful and timely screening strategy, which, in turn, requires cooperation between disciplines and good collaborative links at all stages of the disease. Establishment of a disease registry for SSc may also be of benefit, as such registries facilitate longitudinal observation of trends in disease presentation, management and outcome. They may also help to determine potential risk factors and identify those patient subgroups that face the highest risk of developing disease. In patients with known or suspected SSc, a panel of disease-specific markers—such as autoantibodies, cell activation markers and markers of organ involvement—may help to establish the diagnosis and assess prognosis; however, changes in serum levels of such markers throughout the course of SSc should be interpreted with caution, as they may not always correlate with disease activity. Nail-fold capillaroscopy is a promising tool for SSc assessment and may provide useful diagnostic and prognostic information, although further research is required to clarify its role in evaluating disease evolution.

KEY WORDS: SSc, Early diagnosis, Capillaroscopy, Cross-disciplinary communication

Submitted 12 February 2008; revised version accepted 1 December 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.